advertisement
3.8 Pharmacology (113)
Showing records 1 to 25
Display all abstracts in classification 3.8 Pharmacology
Search within classification 3.8 Pharmacology90781 Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts
Stahnke T
Royal Society open science 2020; 7: 200441
90393 Targeting HDAC3 in the DBA/2J spontaneous mouse model of glaucoma
Schmitt HM
Experimental Eye Research 2020; 200: 108244
90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Xu LJ
Neuropharmacology 2020; 178: 108228
90787 Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
Fachim HA
Journal of biochemical and molecular toxicology 2020; 34: e22578
90580 Neuroprotective role of phosphoserine in primary open-angle glaucoma patients
Scalinci SZ
European review for medical and pharmacological sciences 2020; 24: 9780-9786
90819 Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
Mishra CB
Medicinal Research Reviews 2020; 40: 2485-2565
90767 Cannabinoids and the eye
Wang MTM
Survey of Ophthalmology 2021; 66: 327-345
90249 Understanding metabolism related differences in ocular efficacy of MGV354
Dumouchel JL
Xenobiotica; the fate of foreign compounds in biological systems 2021; 51: 5-14
90006 Aqueous humor renin, angiotensin I, and angiotensin II activity in primary open-angle glaucoma
Seki VBB
Arquivos Brasileiros de Oftalmologia 2020; 83: 318-322
90259 Anti-fibrotic effects of rosmarinic acid on Tenon's capsule fibroblasts stimulated with TGF-β: therapeutic potential in ocular surgery
Módulo CM
Arquivos Brasileiros de Oftalmologia 2020; 83: 305-311
90423 PnPP-19 Peptide as a Novel Drug Candidate for Topical Glaucoma Therapy Through Nitric Oxide Release
da Silva CN
Translational vision science & technology 2020; 9: 33
90759 Rottlerin acts as a therapeutic in primary open-angle glaucoma by targeting the trabecular meshwork via activation of Rap1 signaling
Zhu J
Pharmacological Research 2020; 159: 104780
90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Wang F
European Journal of Pharmacology 2020; 884: 173369
90139 Betalain exerts a protective effect against glaucoma is majorly through the association of inflammatory cytokines
Wang J
AMB Express 2020; 10: 125
90614 Cytoprotective Effect of Astaxanthin in a Model of Normal Intraocular Pressure Glaucoma
Kikuchi K
Journal of Ophthalmology 2020; 2020: 9539681
89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Froger N
Scientific reports 2020; 10: 12409
90333 P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
Romano GL
Biochemical Pharmacology 2020; 180: 114199
90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Ma F
European Journal of Pharmacology 2020; 884: 173369
90259 Anti-fibrotic effects of rosmarinic acid on Tenon's capsule fibroblasts stimulated with TGF-β: therapeutic potential in ocular surgery
Ferreira LD
Arquivos Brasileiros de Oftalmologia 2020; 83: 305-311
90006 Aqueous humor renin, angiotensin I, and angiotensin II activity in primary open-angle glaucoma
Souza GR
Arquivos Brasileiros de Oftalmologia 2020; 83: 318-322
90759 Rottlerin acts as a therapeutic in primary open-angle glaucoma by targeting the trabecular meshwork via activation of Rap1 signaling
Wang Y
Pharmacological Research 2020; 159: 104780
90781 Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts
Gajda-Deryło B
Royal Society open science 2020; 7: 200441
89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Matonti F
Scientific reports 2020; 10: 12409
90139 Betalain exerts a protective effect against glaucoma is majorly through the association of inflammatory cytokines
Zhang D
AMB Express 2020; 10: 125
90819 Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
Tiwari M
Medicinal Research Reviews 2020; 40: 2485-2565
